[1] Potter D.D., Kendrick M.L. An elderly woman with recurrent hyperparathyroidism, The Journal of Family practice Google Scholar

[2] Fernandez-Ranvier G.G., Khanafshar E., Tacha D., Wong M., Kebebew E. et al. Defining a molecular phenotype for benign and malignant parathyroid tumors, Cancer. — 2009, vol. 115, no. 2, 334–344 http://dx.doi.org/10.1002/cncr.24037CrossrefGoogle Scholar

[3] Stephen A.E., Roth S.I., Fardo D.W., Finkelstein D.M., Randolph G.W. et al. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas, Arch Surg. — 2007, vol. 142, no. 4, 381–386 http://dx.doi.org/10.1001/archsurg.142.4.381Web of ScienceCrossrefGoogle Scholar

[4] Tublin M.E., Yim J.H., Carty S.E. Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings, J Ultrasound Med. — 2007, vol. 26,iss. 6, 847–851 Google Scholar

[5] A. Šlepavičius, V. Beiša, V. Janušonis, K. Strupas, Focused versus conventional parathyroidectomy for primary hyperparathyroidism: a prospective, randomized, blinded trial, Langenbecks archives of surgery 2008, 393:659–666 http://dx.doi.org/10.1007/s00423-008-0408-1CrossrefWeb of ScienceGoogle Scholar

[6] Obara T., Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review, World J Surg. — 1991, vol. 15, no. 6, 738–744 http://dx.doi.org/10.1007/BF01665308CrossrefGoogle Scholar

[7] Shane E. Clinical review 122: parathyroid carcinoma, J Clin Endocrinol Metab. — 2001, vol. 86, no. 2, 485–493 http://dx.doi.org/10.1210/jc.86.2.485CrossrefGoogle Scholar

[8] Mihai R., Gleeson F., Buley I.D., Roskell D.E., Sadler G.P. et al. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients, World J Surg. — 2006, vol. 30, no. 5, 697–704 http://dx.doi.org/10.1007/s00268-005-0338-9CrossrefGoogle Scholar

[9] Sahasranam P., Tran M.T., Mohamed H., Friedman T.C. Multiglandular parathyroid carcinoma: a case report and brief review, South Med J. — 2007, vol. 100, no. 8, 841–844 http://dx.doi.org/10.1097/SMJ.0b013e318073ca37Web of ScienceCrossrefGoogle Scholar

[10] Chang Y.J., Mittal V., Remine S., Manyam H., Sabir M. et al. Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma, Am Surg. — 2006, vol. 72, no. 5, 419–426 Google Scholar

[11] Udelsman R., Donovan P.I. Remedial parathyroid surgery: changing trends in 130 consecutive cases, Ann Surg. — 2006, vol. 244,iss. 3, 471–479 Google Scholar

[12] Placzkowski K., Christian R., Chen H. Radioguided parathyroidectomy for recurrent parathyroid cancer, Clin Nucl Med. — 2007, vol. 32,iss. 5, 358–360. http://dx.doi.org/10.1097/01.rlu.0000259623.79805.2dCrossrefGoogle Scholar

[13] Chiu B., Sturgeon C., Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients, Arch Surg. — 2006, vol. 141, no. 5, 483–487 http://dx.doi.org/10.1001/archsurg.141.5.483CrossrefGoogle Scholar

[14] Iihara M., Okamoto T., Suzuki R., Kawamata A., Nishikawa T. et al. Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis, Surgery. — 2007, vol. 142,iss. 6, p. 936–943; discussion 943 e1 http://dx.doi.org/10.1016/j.surg.2007.09.014CrossrefGoogle Scholar

[15] Daphnis E., Stylianou K., Katsipi I., Stratigis S., Karamitopoulou E. et al. Parathyromatosis and the challenge of treatment, Am J Kidney Dis. — 2006, vol. 48,iss. 3, 502–505 http://dx.doi.org/10.1053/j.ajkd.2006.05.010CrossrefGoogle Scholar

[16] Carpenter J., Michaelson P., Linder T., Hinni M. Parathyromatosis, Ear Nose Throat J. — 2007, vol. 86,iss. 1, 21 Google Scholar